Fusion Antibodies on recovery tack after float disruption
The reason for the IPO was to provide funds to expand and Fusion has kept to its plans.
Company
Fusion Antibodies PLC
LON:FAB
Fusion is a Belfast based contract research organisation ("CRO") providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications. The Company's ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation
27 stories · page 2 of 2
Builders and building materials
FTSE 100 sticks on firm ground as US stocks bounce higher on Cyber Monday
The FTSE 100 was set to break a losing streak, rising 58 points
Archive
Christmas lights starting to peek out from under spreadsheets as updates slow in last week of November
The Week Ahead will bring a hotch-potch of updates from the likes of blue-chip Intertek Group, and mid caps Thomas Cook, Pennon, Greene King, Go-Ahead Group, and Britvic
Investments and investor services
Mincon Group rises as profit margins recover
A look at the day's big share price movements, including Mincon Group, TomCo, Chemring, Echo Energy, Paddy Power, BAE Systems, Ocean Wilsons and Fusion Antibodies
Fusion Antibodies plunges after significant lowering of forecast for 2019 financial year
The AIM-listed antibody developer said that delays in securing some large contracts, in addition to slower than anticipated trading in the current period had led to the downgrade
FTSE 100 closes in red as traders fret about Turkey crisis
The UK benchmark of leading shares closed down over 24 points at 7,642.